The effectiveness of CRISPR therapy for angioedema was confirmed in phase II trials.
Danny Cohn of the University of Amsterdam and colleagues from six countries reported the success of a phase II in vivo clinical trial of CRISPR therapy for hereditary angioedema. The experimental drug, NTLA-2002, contains packaged…
